Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 69

1.

HIV-infected adolescents in southern Africa can achieve good treatment outcomes: results from a retrospective cohort study.

Shroufi A, Gunguwo H, Dixon M, Nyathi M, Ndebele W, Saint-Sauveur JF, Taziwa F, Ferreyra C, Viñoles MC, Ferrand RA.

AIDS. 2013 Jul 31;27(12):1971-8.

2.

Risk of death among those awaiting treatment for HIV infection in Zimbabwe: adolescents are at particular risk.

Shroufi A, Ndebele W, Nyathi M, Gunguwo H, Dixon M, Saint-Sauveur JF, Taziwa F, Viñoles MC, Ferrand RA.

J Int AIDS Soc. 2015 Feb 23;18:19247. doi: 10.7448/IAS.18.1.19247. eCollection 2015.

3.

Modelling adverse treatment outcomes of HIV-infected adolescents attending public-sector HIV clinics in Lusaka.

Fwemba I, Musonda P.

Public Health. 2017 Jun;147:8-14. doi: 10.1016/j.puhe.2017.01.022. Epub 2017 Mar 6.

PMID:
28404502
4.

Treatment outcomes of HIV-infected adolescents attending public-sector HIV clinics across Gauteng and Mpumalanga, South Africa.

Evans D, Menezes C, Mahomed K, Macdonald P, Untiedt S, Levin L, Jaffray I, Bhana N, Firnhaber C, Maskew M.

AIDS Res Hum Retroviruses. 2013 Jun;29(6):892-900. doi: 10.1089/AID.2012.0215. Epub 2013 Feb 25.

5.

Treatment outcomes in HIV-infected adolescents attending a community-based antiretroviral therapy clinic in South Africa.

Nglazi MD, Kranzer K, Holele P, Kaplan R, Mark D, Jaspan H, Lawn SD, Wood R, Bekker LG.

BMC Infect Dis. 2012 Jan 25;12:21. doi: 10.1186/1471-2334-12-21.

6.

Risk factors associated with increased mortality among HIV infected children initiating antiretroviral therapy (ART) in South Africa.

Zanoni BC, Phungula T, Zanoni HM, France H, Feeney ME.

PLoS One. 2011;6(7):e22706. doi: 10.1371/journal.pone.0022706. Epub 2011 Jul 29.

7.

Retention in care among HIV-positive patients initiating second-line antiretroviral therapy: a retrospective study from an Ethiopian public hospital clinic.

Wilhelmson S, Reepalu A, Balcha TT, Jarso G, Björkman P.

Glob Health Action. 2016 Jan 12;9:29943. doi: 10.3402/gha.v9.29943. eCollection 2016.

8.

Outcomes of a nurse-managed service for stable HIV-positive patients in a large South African public sector antiretroviral therapy programme.

Grimsrud A, Kaplan R, Bekker LG, Myer L.

Trop Med Int Health. 2014 Sep;19(9):1029-39. doi: 10.1111/tmi.12346. Epub 2014 Jul 8.

9.

Similar mortality and reduced loss to follow-up in integrated compared with vertical programs providing antiretroviral treatment in sub-saharan Africa.

Greig J, O'Brien DP, Ford N, Spelman T, Sabapathy K, Shanks L.

J Acquir Immune Defic Syndr. 2012 Apr 15;59(5):e92-8. doi: 10.1097/QAI.0b013e31824206c7.

PMID:
22134144
10.
11.

Antiretroviral therapy adherence, virologic and immunologic outcomes in adolescents compared with adults in southern Africa.

Nachega JB, Hislop M, Nguyen H, Dowdy DW, Chaisson RE, Regensberg L, Cotton M, Maartens G.

J Acquir Immune Defic Syndr. 2009 May 1;51(1):65-71. doi: 10.1097/QAI.0b013e318199072e.

12.

Survival of HIV-infected adolescents on antiretroviral therapy in Uganda: findings from a nationally representative cohort in Uganda.

Bakanda C, Birungi J, Mwesigwa R, Nachega JB, Chan K, Palmer A, Ford N, Mills EJ.

PLoS One. 2011 Apr 29;6(4):e19261. doi: 10.1371/journal.pone.0019261.

13.

Incorporating loss to follow-up in estimates of survival among HIV-infected individuals in sub-Saharan Africa enrolled in antiretroviral therapy programs.

Verguet S, Lim SS, Murray CJ, Gakidou E, Salomon JA.

J Infect Dis. 2013 Jan 1;207(1):72-9. doi: 10.1093/infdis/jis635. Epub 2012 Oct 24.

PMID:
23100567
14.

Optimal monitoring strategies for guiding when to switch first-line antiretroviral therapy regimens for treatment failure in adults and adolescents living with HIV in low-resource settings.

Chang LW, Harris J, Humphreys E.

Cochrane Database Syst Rev. 2010 Apr 14;(4):CD008494. doi: 10.1002/14651858.CD008494. Review.

PMID:
20393969
15.

Prognostic value of virological and immunological responses after 6 months of antiretroviral treatment in adults with HIV-1 infection in sub-Saharan Africa.

De Luca A, Marazzi MC, Mancinelli S, Ceffa S, Altan AM, Buonomo E, Prosperi MC, Pedruzzi B, Noorjehan AM, Scarcella P, Liotta G, Palombi L.

J Acquir Immune Defic Syndr. 2012 Mar 1;59(3):236-44. doi: 10.1097/QAI.0b013e31824276e9.

PMID:
22327246
16.

Antiretroviral therapy (ART) for treating HIV infection in ART-eligible pregnant women.

Sturt AS, Dokubo EK, Sint TT.

Cochrane Database Syst Rev. 2010 Mar 17;(3):CD008440. doi: 10.1002/14651858.CD008440. Review.

PMID:
20238370
17.

Low risk of death, but substantial program attrition, in pediatric HIV treatment cohorts in Sub-Saharan Africa.

KIDS-ART-LINC Collaboration.

J Acquir Immune Defic Syndr. 2008 Dec 15;49(5):523-31. doi: 10.1097/QAI.0b013e31818aadce.

PMID:
18989227
18.

Adults receiving HIV care before the start of antiretroviral therapy in sub-Saharan Africa: patient outcomes and associated risk factors.

Bastard M, Nicolay N, Szumilin E, Balkan S, Poulet E, Pujades-Rodriguez M.

J Acquir Immune Defic Syndr. 2013 Dec 15;64(5):455-63. doi: 10.1097/QAI.0b013e3182a61e8d.

PMID:
23892242
19.

Association of adherence support and outreach services with total attrition, loss to follow-up, and death among ART patients in sub-Saharan Africa.

Lamb MR, El-Sadr WM, Geng E, Nash D.

PLoS One. 2012;7(6):e38443. doi: 10.1371/journal.pone.0038443. Epub 2012 Jun 7.

20.

Self-reported dietary intake and appetite predict early treatment outcome among low-BMI adults initiating HIV treatment in sub-Saharan Africa.

Koethe JR, Blevins M, Bosire C, Nyirenda C, Kabagambe EK, Mwango A, Kasongo W, Zulu I, Shepherd BE, Heimburger DC.

Public Health Nutr. 2013 Mar;16(3):549-58. doi: 10.1017/S1368980012002960. Epub 2012 Jun 13.

Supplemental Content

Support Center